Close Menu

NEW YORK – Belgian oncology molecular diagnostics firm Biocartis said on Wednesday that it has received a €1.2 million ($1.4 million) grant from the Agency for Innovation and Entrepreneurship (VLAIO), a Flemish government organization, to develop its GeneFusion assay on the Idylla instrument.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.